IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,684,230 | +74.6% | 1,520,097 | -40.7% | 0.17% | +16.9% |
| Q4 2017 | $16,432,000 | -20.1% | 2,563,489 | -4.6% | 0.14% | -15.0% |
| Q3 2017 | $20,567,000 | -4.1% | 2,688,489 | -10.8% | 0.17% | -10.7% |
| Q2 2017 | $21,439,000 | +83.7% | 3,015,353 | 0.0% | 0.19% | +96.8% |
| Q1 2017 | $11,669,000 | +89.7% | 3,015,353 | 0.0% | 0.10% | +58.3% |
| Q4 2016 | $6,151,000 | -23.9% | 3,015,353 | 0.0% | 0.06% | -17.8% |
| Q3 2016 | $8,081,000 | -13.0% | 3,015,353 | 0.0% | 0.07% | -24.7% |
| Q2 2016 | $9,287,000 | -75.5% | 3,015,353 | -32.3% | 0.10% | -75.8% |
| Q1 2016 | $37,935,000 | -37.2% | 4,452,445 | 0.0% | 0.40% | -20.2% |
| Q4 2015 | $60,420,000 | +77.4% | 4,452,445 | +25.5% | 0.50% | +59.0% |
| Q3 2015 | $34,061,000 | +2.1% | 3,548,040 | +52.9% | 0.32% | +7.5% |
| Q2 2015 | $33,368,000 | +273.0% | 2,320,424 | +132.2% | 0.29% | +295.9% |
| Q1 2015 | $8,945,000 | – | 999,496 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |